AIM
FSTX

Alambic Investment Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Alambic Investment Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,525
Closed -$16K – 295
2019
Q4 		$16K Buy
+2,525
New +$32.1K 0.01% 280

Other funds holding FSTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
ED
Exane Derivatives Paris, France $174M AUM 7.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Alambic Investment Management's FSTX Position: Q1 2020 in Review

Alambic Investment Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2020, closing a stake of 2,525 shares — an estimated $16K sold.

Alambic Investment Management first reported a position in FSTX in Q4 2019 and held it in 1 quarter. The position peaked at $16K in Q4 2019. 28 funds tracked by Wall St. Rank hold FSTX as of Q1 2020.

  • Alambic Investment Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Alambic Investment Management sold 2,525 F-star Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $16K.
  • Alambic Investment Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Alambic Investment Management's F-star Therapeutics, Inc. Common Stock position peaked at $16K in Q4 2019.
  • 28 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Alambic Investment Management's 13F filing for Q1 2020, filed 11 May 2020.